Sunday, 21 September 2014
Last updated 2 days ago
Dec 15 2010 | 10:13am ET
Last month, FrontPoint Partners shuttered its healthcare hedge funds in the wake of an insider-trading investigation. And with no more healthcare funds, the embattled firm saw no reason to continue paying its healthcare team.
Greenwich, Conn.-based FrontPoint cut the entire 12-person team working on the funds at the beginning of November, according to published reports. The move came shortly after FrontPoint, which recently spun off from Morgan Stanley, acknowledged that Joseph Skowron, its lead healthcare manager, was the unidentified hedge fund manager named in the criminal complaint against a French doctor.
That doctor, Yves Benhamou, was accused of passing confidential information on the results of a drug trial to at least six hedge funds, among them FrontPoint. While neither the firm nor Skowron have been charged with any wrongdoing, FrontPoint suspended him pending an investigation.
Despite the lack of charges, investors began fleeing the $1.5 billion funds—as well as other FrontPoint funds. The firm has been hit with some $3 billion in redemption requests.
Last week, FrontPoint laid off more than two dozen non-investment staffers as it moves to cut costs in the face of the redemptions. The firm employed 219 people as of the end of September.
Aug 25 2014 | 11:21am ET
As many of you know, FINalternatives was recently acquired by the owners of Futures magazine, a firm called The Alpha Pages LLC. Today marks the soft-launch of a new sister site for both publications. As its name suggests, The Alpha Pages will cover all types of alternative investments, going far beyond the more well-known ones such as hedge funds and private equity. Read more…
Credit default swaps brought down the London Whale and cost JPMorgan $6.2 billion. Here is how it happened.